cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
YCBD.PRA was delisted on the 5th of May, 2025.
6 hedge funds and large institutions have $173K invested in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
36% more capital invested
Capital invested by funds: $127K → $173K (+$45.8K)
0% more funds holding
Funds holding: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
+$19.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.87K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$3.14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CD
1
Chapin Davis
Baltimore,
Maryland
| $66.2K | – | – | – |
|
|
CL
2
CSS LLC
Chicago,
Illinois
| $61.6K | – | – | – |
|
|
MG
3
Marex Group
London,
| $33.7K | +$19.7K | +29,485 | +263% |
|
4
Commonwealth Equity Services
Waltham,
Massachusetts
| $8K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $2.48K | +$1.87K | +2,799 | +1,393% |
|
|
6
Morgan Stanley
New York
| $580 | -$3.14K | -4,700 | -87% |
|
YCBD.PRA Hedge Fund Activity: Q1 2024 in Review
6 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) for Q1 2024, worth a combined $173K — up 36% from $127K a quarter earlier.
Fund positioning in YCBD.PRA was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Marex Group, adding an estimated $19.7K. The largest seller was Morgan Stanley, cutting an estimated $3.14K.
- 6 institutional investors held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $173K of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock stock for Q1 2024, up 36% quarter-over-quarter.
- 0 funds opened new cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock positions in Q1 2024 and 0 closed out.
- The largest cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock buyer in Q1 2024 was Marex Group, an estimated $19.7K added.
- The largest cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock seller in Q1 2024 was Morgan Stanley, an estimated $3.14K sold.
Based on aggregated 13F filings for Q1 2024.